Niveles de fosfolipasa A2 asociada a lipoproteína en sujetos sin enfermedad coronaria con riesgo cardiovascular variable
Background: Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an inflammatory biomarker involved in atherosclerosis and directly associated with cardiovascular events. Aim: To determine Lp-PLA2 levels in asymptomatic subjects with differing cardiovascular risk. Material and Methods: We studied 15...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2013
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013001100003 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872013001100003 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720130011000032014-09-01Niveles de fosfolipasa A2 asociada a lipoproteína en sujetos sin enfermedad coronaria con riesgo cardiovascular variableAcevedo,MónicaVarleta,PaolaKramer,VerónicaQuiroga,TeresaPrieto,CarolinaParada,JacquelineAdasme,MarcelaBriones,LuisaNavarrete,Carlos Inflammation Lipoprotein associated phospholipase A (2) Risk factors Background: Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an inflammatory biomarker involved in atherosclerosis and directly associated with cardiovascular events. Aim: To determine Lp-PLA2 levels in asymptomatic subjects with differing cardiovascular risk. Material and Methods: We studied 152 subjects aged 46 ± 11 years (69 women). We recorded traditional cardiovascular risk factors, creatinine, ultrasensitive C-reactive protein, fibrinogen, fasting lipids, blood sugar and activity levels of Lp-PLA2. Cardiovascular risk was classified according to the number of risk factors of each subject (0,1-2 or ≥ 3 risk factors). Besides, we calculated global Framingham risk score. Results: The average Framingham score of participants was 6%. Twenty percent of participants had no risk factors, 46% had 1 or 2 and 34% had ≥ 3. Mean Lp-PLA2 levels were 185 ± 48 nmol/ml/min (201 ± 49 in men and 166 ± 38 in women). Lp-PLA2 correlated significantly (p < 0,05 for all) with non-HDL cholesterol, LDL, HDL, creatinine, waist circumference, body mass index and Framingham risk score. There was no correlation with blood sugar, C-reactive protein, fibrinogen or smoking status. Lp-PLA2 levels were significantly higher according to the number of risk factors: 0 factors: 163 ± 43, 1-2 factors: 185 ± 45 and ≥ 3 factors: 201 ± 47 nmol/ml/min, respectively. Linear regression analysis showed that the best predictor of Lp-PLA2 was non-HDL cholesterol (β = 0,74; p < 0,0001). Conclusions: Lp-PLA2 activity increased along with the number of cardiovascular risk factors and was correlated mainly with non -HDL cholesterol.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.141 n.11 20132013-11-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013001100003es10.4067/S0034-98872013001100003 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Inflammation Lipoprotein associated phospholipase A (2) Risk factors |
spellingShingle |
Inflammation Lipoprotein associated phospholipase A (2) Risk factors Acevedo,Mónica Varleta,Paola Kramer,Verónica Quiroga,Teresa Prieto,Carolina Parada,Jacqueline Adasme,Marcela Briones,Luisa Navarrete,Carlos Niveles de fosfolipasa A2 asociada a lipoproteína en sujetos sin enfermedad coronaria con riesgo cardiovascular variable |
description |
Background: Lipoprotein-associated phospholipase A2 (Lp-PLA2) is an inflammatory biomarker involved in atherosclerosis and directly associated with cardiovascular events. Aim: To determine Lp-PLA2 levels in asymptomatic subjects with differing cardiovascular risk. Material and Methods: We studied 152 subjects aged 46 ± 11 years (69 women). We recorded traditional cardiovascular risk factors, creatinine, ultrasensitive C-reactive protein, fibrinogen, fasting lipids, blood sugar and activity levels of Lp-PLA2. Cardiovascular risk was classified according to the number of risk factors of each subject (0,1-2 or ≥ 3 risk factors). Besides, we calculated global Framingham risk score. Results: The average Framingham score of participants was 6%. Twenty percent of participants had no risk factors, 46% had 1 or 2 and 34% had ≥ 3. Mean Lp-PLA2 levels were 185 ± 48 nmol/ml/min (201 ± 49 in men and 166 ± 38 in women). Lp-PLA2 correlated significantly (p < 0,05 for all) with non-HDL cholesterol, LDL, HDL, creatinine, waist circumference, body mass index and Framingham risk score. There was no correlation with blood sugar, C-reactive protein, fibrinogen or smoking status. Lp-PLA2 levels were significantly higher according to the number of risk factors: 0 factors: 163 ± 43, 1-2 factors: 185 ± 45 and ≥ 3 factors: 201 ± 47 nmol/ml/min, respectively. Linear regression analysis showed that the best predictor of Lp-PLA2 was non-HDL cholesterol (β = 0,74; p < 0,0001). Conclusions: Lp-PLA2 activity increased along with the number of cardiovascular risk factors and was correlated mainly with non -HDL cholesterol. |
author |
Acevedo,Mónica Varleta,Paola Kramer,Verónica Quiroga,Teresa Prieto,Carolina Parada,Jacqueline Adasme,Marcela Briones,Luisa Navarrete,Carlos |
author_facet |
Acevedo,Mónica Varleta,Paola Kramer,Verónica Quiroga,Teresa Prieto,Carolina Parada,Jacqueline Adasme,Marcela Briones,Luisa Navarrete,Carlos |
author_sort |
Acevedo,Mónica |
title |
Niveles de fosfolipasa A2 asociada a lipoproteína en sujetos sin enfermedad coronaria con riesgo cardiovascular variable |
title_short |
Niveles de fosfolipasa A2 asociada a lipoproteína en sujetos sin enfermedad coronaria con riesgo cardiovascular variable |
title_full |
Niveles de fosfolipasa A2 asociada a lipoproteína en sujetos sin enfermedad coronaria con riesgo cardiovascular variable |
title_fullStr |
Niveles de fosfolipasa A2 asociada a lipoproteína en sujetos sin enfermedad coronaria con riesgo cardiovascular variable |
title_full_unstemmed |
Niveles de fosfolipasa A2 asociada a lipoproteína en sujetos sin enfermedad coronaria con riesgo cardiovascular variable |
title_sort |
niveles de fosfolipasa a2 asociada a lipoproteína en sujetos sin enfermedad coronaria con riesgo cardiovascular variable |
publisher |
Sociedad Médica de Santiago |
publishDate |
2013 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013001100003 |
work_keys_str_mv |
AT acevedomonica nivelesdefosfolipasaa2asociadaalipoproteinaensujetossinenfermedadcoronariaconriesgocardiovascularvariable AT varletapaola nivelesdefosfolipasaa2asociadaalipoproteinaensujetossinenfermedadcoronariaconriesgocardiovascularvariable AT kramerveronica nivelesdefosfolipasaa2asociadaalipoproteinaensujetossinenfermedadcoronariaconriesgocardiovascularvariable AT quirogateresa nivelesdefosfolipasaa2asociadaalipoproteinaensujetossinenfermedadcoronariaconriesgocardiovascularvariable AT prietocarolina nivelesdefosfolipasaa2asociadaalipoproteinaensujetossinenfermedadcoronariaconriesgocardiovascularvariable AT paradajacqueline nivelesdefosfolipasaa2asociadaalipoproteinaensujetossinenfermedadcoronariaconriesgocardiovascularvariable AT adasmemarcela nivelesdefosfolipasaa2asociadaalipoproteinaensujetossinenfermedadcoronariaconriesgocardiovascularvariable AT brionesluisa nivelesdefosfolipasaa2asociadaalipoproteinaensujetossinenfermedadcoronariaconriesgocardiovascularvariable AT navarretecarlos nivelesdefosfolipasaa2asociadaalipoproteinaensujetossinenfermedadcoronariaconriesgocardiovascularvariable |
_version_ |
1718436720522821632 |